CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, cilt.15, sa.1, ss.59-63, 2017 (SCI-Expanded)
Objective: The present study aims to analyze the levels of resistin, tumor necrosis factor alpha (TNF-alpha), interleukin (IL)-1 beta, IL-6, IL-18, and C-reactive protein (CRP) in patients with Alzheimer's disease (AD) and also investigate a potential relationship between resistin levels and TNF-alpha, IL-1 beta, IL-6, IL-18, and CRP levels in patients with AD.